Welcome to our dedicated page for CXApp SEC filings (Ticker: CXAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CXApp Inc. filings document the public-company disclosures of an AI workplace experience and spatial intelligence software issuer with Nasdaq-listed common stock and warrants. Its current reports include capital-structure activity, unregistered common stock issuances, pre-paid purchase arrangements with Avondale Capital, and material-agreement disclosures.
The company’s SEC record also covers Nasdaq continued-listing matters, proxy and governance disclosures, shareholder voting items, operating and financial results, securities registration details, risk-related language, and formal descriptions of its common stock and warrant classes.
CXApp Inc. reported an unregistered sale of equity securities. The company issued an aggregate of 4,116,659 shares of common stock to Avondale Capital, LLC under two Pre-Paid Purchase agreements entered into pursuant to a Securities Purchase Agreement dated March 26, 2025.
The shares were issued on March 30, 2026, April 1, 2026, April 8, 2026 and April 10, 2026 at per-share prices of $0.180453, $0.18045, $0.154427 and $0.154427, respectively. The transaction relied on the Section 4(a)(2) exemption from registration for offerings not involving a public offering.
CXApp Inc. provides an AI-powered, mobile-first employee experience SaaS platform that helps enterprises manage hybrid workplaces, space utilization and engagement, backed by 37 filed patents, including 17 granted. Customers are largely Fortune 1000 firms across technology, financial services, manufacturing, entertainment and life sciences.
The company remains unprofitable, with net losses of $13.5 million in 2025 and $19.4 million in 2024, and a workforce of about 35 employees as of March 24, 2026. It recorded a $2.1 million goodwill impairment in 2025 and depends heavily on a few large customers; the top three represented about 40% of 2025 revenue.
CXApp previously reported material weaknesses in internal control but states these were remediated by December 31, 2025. Its stock faces Nasdaq minimum bid price noncompliance, with an extension to September 7, 2026 to regain a bid of at least $1.00 for 10 consecutive business days, or risk delisting.
CXApp Inc. reported issuing 10,028,891 shares of common stock to Avondale Capital, LLC in a private transaction under prior pre-paid purchase arrangements tied to a 2025 securities purchase agreement. The shares were delivered on multiple dates in February and March 2026 at prices between $0.156793 and $0.199381 per share, relying on an exemption from Securities Act registration for transactions not involving a public offering.
CXApp Inc. disclosed that Nasdaq has granted it an additional 180-day grace period, until September 7, 2026, to regain compliance with Nasdaq’s minimum bid price rule. The company’s stock had traded below the required $1.00 per share for at least 30 consecutive business days, triggering the deficiency notice.
The extension allows CXApp’s common stock to continue trading on the Nasdaq Capital Market while it works to cure the issue. The company has informed Nasdaq it intends to address the deficiency, potentially through a reverse stock split if needed. If the closing bid is at or above $1.00 for at least ten consecutive trading days before the deadline, compliance will be restored. Failure to do so could lead to delisting, although CXApp would have the right to appeal.
CXApp Inc. files a prospectus supplement registering the resale of up to 10,026,776 shares of common stock. The supplement also covers resale of up to 10,280,000 private placement warrants, 24,080,000 shares of common stock underlying warrants, and specified resale rights of Streeterville Capital under existing agreements.
The supplement incorporates a Form 8-K reporting that Nasdaq granted an additional compliance period through September 7, 2026 to meet the $1.00 minimum bid price requirement; the company reported closing prices of $0.21 per share and $0.066 per warrant on March 11, 2026.
CXApp Inc. reported that it issued 4,616,481 shares of its common stock to Avondale Capital, LLC in a private transaction. The shares were delivered under a Pre-Paid Purchase #1 dated March 26, 2025, entered into pursuant to a Securities Purchase Agreement between the two parties.
The common shares were issued on January 26, 2026, January 27, 2026 and January 28, 2026 at a price of $0.24024 per share. CXApp relied on Section 4(a)(2) of the Securities Act of 1933, using an exemption for transactions not involving a public offering, which means these shares were sold without SEC registration and increase the company’s outstanding share count.
CXApp Inc. filed a prospectus supplement covering the resale of up to 10,026,776 shares of common stock, 10,280,000 warrants, and 24,080,000 shares of common stock underlying those warrants by selling securityholders. The supplement incorporates a Current Report on Form 8-K.
The attached Form 8-K discloses that CXApp issued 4,616,481 shares of common stock to Avondale Capital, LLC under a pre-paid purchase agreement at $0.24024 per share, with issuances on January 26, 27 and 28, 2026, relying on the private offering exemption in Section 4(a)(2) of the Securities Act. CXApp’s common stock and warrants trade on Nasdaq under the symbols CXAI and CXAIW, with recent closing prices of $0.305 per share and $0.0327 per warrant, respectively.
CXApp Inc. has filed a prospectus supplement covering the resale of up to 10,026,776 shares of common stock, along with 10,280,000 warrants and 24,080,000 shares of common stock underlying those warrants by existing securityholders. The supplement incorporates a new current report and must be read together with the base prospectus dated October 3, 2024.
Separately, CXApp disclosed that it issued 3,266,615 shares of common stock to Avondale Capital, LLC under a pre-paid purchase arrangement, at a price of $0.348985 per share, in a private offering relying on an exemption from registration. The company’s common stock and warrants trade on Nasdaq under the symbols CXAI and CXAIW, with recent closing prices of $0.4654 per share and $0.0778 per warrant.
CXApp Inc. reported that it issued 3,266,615 shares of common stock to Avondale Capital, LLC at a price of $0.348985 per share in an unregistered, non-public offering. The shares were delivered on December 9, 2025 and December 10, 2025 under a Pre-Paid Purchase #1 dated March 26, 2025, which is tied to a Securities Purchase Agreement between the two parties.
The company states that the offer and sale were conducted in reliance on Section 4(a)(2) of the Securities Act for transactions not involving a public offering, meaning the shares were not registered with the SEC for public sale. CXApp also reiterates a broad set of business risks and uncertainties, including demand for its services, competitive pressures, regulatory changes, management continuity, and potential loss of major customers.
CXApp Inc. filed a prospectus supplement for the resale of up to 10,026,776 shares of common stock, together with 10,280,000 warrants and 24,080,000 shares issuable upon warrant exercise, by selling securityholders. Components include 6,977,776 previously issued shares, 10,280,000 private placement warrants, 13,800,000 public-warrant shares and 10,280,000 private-warrant shares, plus up to 40,000 shares and up to 3,009,000 shares related to a May 22, 2024 financing.
The supplement attaches CXApp’s quarterly report. For the quarter ended September 30, 2025, revenue was $1.114 million versus $1.897 million a year ago, with a net loss of $3.157 million versus $5.434 million. Cash and cash equivalents were $5.088 million. Management disclosed recurring losses and cash use that raise doubt about continuing as a going concern, while citing financing arrangements and cost actions to support operations. As of November 11, 2025, shares outstanding were 28,629,315.
CXApp’s securities trade on Nasdaq as CXAI (common) and CXAIW (warrants).